Katsuhiro Mori

1.3k total citations
11 papers, 1.0k citations indexed

About

Katsuhiro Mori is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Immunology. According to data from OpenAlex, Katsuhiro Mori has authored 11 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 7 papers in Radiology, Nuclear Medicine and Imaging and 5 papers in Immunology. Recurrent topics in Katsuhiro Mori's work include Monoclonal and Polyclonal Antibodies Research (7 papers), Glycosylation and Glycoproteins Research (6 papers) and Galectins and Cancer Biology (3 papers). Katsuhiro Mori is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (7 papers), Glycosylation and Glycoproteins Research (6 papers) and Galectins and Cancer Biology (3 papers). Katsuhiro Mori collaborates with scholars based in Japan and Singapore. Katsuhiro Mori's co-authors include Mitsuo Satoh, Kenya Shitara, Shigeru Iida, Miho Inoue, Reiko Kuni‐Kamochi, Yutaka Kanda, Akira Okazaki, Keiichi Yano, Ryosuke Nakano and Masako Wakitani and has published in prestigious journals such as Journal of Biological Chemistry, FEBS Letters and Biotechnology and Bioengineering.

In The Last Decade

Katsuhiro Mori

11 papers receiving 1000 citations

Peers

Katsuhiro Mori
Hanspeter Amstutz Switzerland
Paula Henderikx Netherlands
Lori O'Connell United States
Helen Chung United States
R A Reisfeld United States
P O Livingston United States
Mei-Sheng Tai United States
Katsuhiro Mori
Citations per year, relative to Katsuhiro Mori Katsuhiro Mori (= 1×) peers Naoko Yamane‐Ohnuki

Countries citing papers authored by Katsuhiro Mori

Since Specialization
Citations

This map shows the geographic impact of Katsuhiro Mori's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katsuhiro Mori with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katsuhiro Mori more than expected).

Fields of papers citing papers by Katsuhiro Mori

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Katsuhiro Mori. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katsuhiro Mori. The network helps show where Katsuhiro Mori may publish in the future.

Co-authorship network of co-authors of Katsuhiro Mori

This figure shows the co-authorship network connecting the top 25 collaborators of Katsuhiro Mori. A scholar is included among the top collaborators of Katsuhiro Mori based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Katsuhiro Mori. Katsuhiro Mori is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Takagi, Yu, et al.. (2022). An effective approach for accurate estimation of VLBI–GNSS local-tie vectors. Earth Planets and Space. 74(1). 3 indexed citations
2.
Iida, Shigeru, Reiko Kuni‐Kamochi, Katsuhiro Mori, et al.. (2009). Two mechanisms of the enhanced antibody-dependent cellular cytotoxicity (ADCC) efficacy of non-fucosylated therapeutic antibodies in human blood. BMC Cancer. 9(1). 58–58. 81 indexed citations
3.
Iida, Shigeru, Hirofumi Misaka, Katsuhiro Mori, et al.. (2009). Nonfucosylated rituximab potentiates human neutrophil phagocytosis through its high binding for FcγRIIIb and MHC class II expression on the phagocytotic neutrophils. Experimental Hematology. 37(3). 309–321. 93 indexed citations
5.
Kanda, Yutaka, Reiko Kuni‐Kamochi, Katsuhiro Mori, et al.. (2007). Establishment of a GDP-mannose 4,6-dehydratase (GMD) knockout host cell line: A new strategy for generating completely non-fucosylated recombinant therapeutics. Journal of Biotechnology. 130(3). 300–310. 91 indexed citations
6.
Mori, Katsuhiro, Shigeru Iida, Naoko Yamane‐Ohnuki, et al.. (2007). Non-fucosylated therapeutic antibodies: the next generation of therapeutic antibodies. Cytotechnology. 55(2-3). 109–114. 80 indexed citations
7.
Yamano, Kazuya, et al.. (2007). Identification of the functional expression of adenosine A3 receptor in pancreas using transgenic mice expressing jellyfish apoaequorin. Transgenic Research. 16(4). 429–435. 13 indexed citations
8.
Kanda, Yutaka, Tsuyoshi Yamada, Katsuhiro Mori, et al.. (2006). Comparison of biological activity among nonfucosylated therapeutic IgG1 antibodies with three different N-linked Fc oligosaccharides: the high-mannose, hybrid, and complex types. Glycobiology. 17(1). 104–118. 305 indexed citations
9.
Mori, Katsuhiro, Reiko Kuni‐Kamochi, Naoko Yamane‐Ohnuki, et al.. (2004). Engineering Chinese hamster ovary cells to maximize effector function of produced antibodies using FUT8 siRNA. Biotechnology and Bioengineering. 88(7). 901–908. 132 indexed citations
10.
Mori, Katsuhiro & Hiroyuki Kato. (2002). A putative nuclear receptor coactivator (TMF/ARA160) associates with hbrm/hSNF2α and BRG‐1/hSNF2β and localizes in the Golgi apparatus. FEBS Letters. 520(1-3). 127–132. 33 indexed citations
11.
Mori, Katsuhiro, Yuichi Maeda, Hirotake Kitaura, et al.. (1998). MM-1, a Novel c-Myc-associating Protein That Represses Transcriptional Activity of c-Myc. Journal of Biological Chemistry. 273(45). 29794–29800. 97 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026